Showing results (211-220 of 292) with videos related to
Sort By:
Pageof 30
Clinical Therapeutics|April 28, 2009
An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.Clinical Therapeutics|January 30, 2010
Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteersBo-Hyung Kim, Kwang-Hee Shin, Jaewoo Kim, et al.Therapeutic Drug Monitoring|May 14, 2013
Population pharmacokinetics of theophylline in premature Korean infantsSung Eun Kim, Bo-Hyung Kim, Seunghwan Lee, et al.Clinical Drug Investigation|March 14, 2014
Pharmacodynamics, pharmacokinetics, and tolerability of intravenous or subcutaneous GC1113, a novel erythropoiesis-stimulating agentHyeKyung Han, Jongtae Lee, Donghoon Shin, et al.Drug Design, Development and Therapy|October 23, 2014
Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteersNamyi Gu, Min Kyu Park, Tae-Eun Kim, et al.Clinical Therapeutics|June 26, 2012
The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trialNamyi Gu, Bo-Hyung Kim, Kyoung Soo Lim, et al.Journal of Cardiovascular Pharmacology|July 19, 2011
The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteersKwang-Hee Shin, Tae-Eun Kim, Sung Eun Kim, et al.British Journal of Clinical Pharmacology|August 30, 2008
Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjectsKyoung Soo Lim, Joo-Youn Cho, In-Jin Jang, et al.British Journal of Clinical Pharmacology|November 27, 2008
Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patientsJung-Ryul Kim, Hyo-Bum Seo, Joo-Youn Cho, et al.Clinical Pharmacology and Therapeutics|October 4, 2005
Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteersJae-Yong Chung, Joo-Youn Cho, Kyung-Sang Yu, et al.Pageof 30